Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01018394 · ClinicalTrials.gov registry record · Phase 2
Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT01018394: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT01018394 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01018394, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
Smokeless tobacco (ST) is a known human carcinogen. Long-term ST use is known to increase the risk for oropharyngeal cancer. Extant literature on cigarette smokers suggests that smoking reduction increases smoking abstinence among smokers not interested in quitting. The overarching goal of this line of research is to develop a ST reduction intervention among ST users not interested in quitting tobacco. Our first step is to conduct the proposed pilot study designed to assess the efficacy of the nicotine lozenges or tobacco-free snuff for reducing ST use or facilitating ST abstinence among ST users not interested in quitting.
Interventions
- DRUG nicotine lozenges
- DRUG tobacco-free snuff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01018394
The ClinicalTrials.gov registry entry for NCT01018394 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nicotine lozenges is the first listed.
NCT01018394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01018394 about?
NCT01018394 is a clinical study titled "Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction". Smokeless tobacco (ST) is a known human carcinogen. Long-term ST use is known to increase the risk for oropharyngeal cancer. Extant literature on cigarette smokers suggests that smoking reduction increases smoking abstinence among smokers not interested in quitting. The overarching goal of this line...
What is the current status of trial NCT01018394?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2009-01. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01018394?
The interventions under investigation include: nicotine lozenges (DRUG), tobacco-free snuff (DRUG).
Who is sponsoring clinical trial NCT01018394?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.